In this episode of The Diary Of A CEO, Dr. Rachel Rubin discusses the state of women's sexual and hormonal health, highlighting significant gaps in medical education and patient care. Rubin explains how hormones like testosterone, estrogen, and progesterone affect women throughout their lives—from menstrual cycles to perimenopause and beyond—and addresses the widespread misinformation surrounding hormone replacement therapy that keeps most eligible women from accessing beneficial treatments.
The conversation covers fundamental aspects of female sexual anatomy, particularly the clitoris and its role in pleasure, as well as common issues like painful sex, difficulty reaching orgasm, and clitoral adhesions that often go undiagnosed. Rubin and Bartlett also explore how communication, lifestyle factors, body image, and understanding different arousal patterns impact intimacy and satisfaction. Throughout, Rubin emphasizes the importance of patient self-advocacy and education in navigating a healthcare system that often fails to adequately address women's sexual and hormonal health needs.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Hormones profoundly influence women's health across all life stages, yet clinical attention and public awareness remain limited due to historical stigma and educational gaps. Rachel Rubin explains that women's [restricted term] levels decline significantly starting in the mid-to-late thirties, well before menopause, leading to decreased libido, reduced clitoral engorgement and lubrication, and slower orgasms. Despite these effects, medical training focuses primarily on estrogen and progesterone, leaving [restricted term] largely overlooked. Birth control pills can further suppress [restricted term], causing painful sex and low libido in some users, prompting Rubin to urge women to discuss alternatives with healthcare providers.
Understanding the menstrual cycle's hormonal patterns is fundamental to women's health. The cycle begins with low estrogen and progesterone during menstruation, followed by rising estrogen in the follicular phase to prepare for ovulation. After ovulation, progesterone dominates the luteal phase, affecting mood, sleep, and sexual interest. [restricted term] peaks during ovulation, coinciding with heightened fertility and increased sexual desire.
Perimenopause typically begins around age 45 but can start as early as 35, bringing hormonal fluctuations that cause hot flashes, sleep disruption, anxiety, cognitive changes, joint pain, and more frequent UTIs. Rubin emphasizes that declining progesterone commonly disrupts sleep and increases anxiety, yet symptoms are frequently misattributed or dismissed due to low awareness of perimenopause's early onset.
Many women avoid hormone therapy due to outdated fears stemming from a misinterpreted early-2000s study, the Women's Health Initiative. Researchers prematurely warned that hormone therapy caused cardiovascular disease and breast cancer, leading to widespread withdrawal from hormone prescriptions. However, a 2025 reanalysis confirmed that hormone therapy under age 70 does not increase cardiovascular or stroke risk. Despite this, only about 1.7% of eligible women receive hormone prescriptions—a public health failure Rubin attributes to physician undertraining.
Rubin defines four categories of hormone therapy that can be individualized to symptoms: whole-body estrogen (for hot flashes, night sweats, and bone loss), whole-body progesterone (for uterine protection, sleep, and anxiety), [restricted term] (for libido, arousal, and orgasm), and vaginal hormones (for urinary issues, recurrent UTIs, painful intercourse, and dryness). Vaginal hormones, delivered as low-dose creams, tablets, or rings, are proven safe for all ages—including postpartum women—and dramatically improve quality of life while preventing UTIs. Rubin stresses that therapy choice should be driven by symptoms, not age, and that initiation should occur when symptoms impact quality of life. Empowering women with accurate information and compassionate, knowledgeable physicians enables informed decisions about hormone health at every stage.
The clitoris is central to women's sexual pleasure, yet it remains poorly understood and barely featured in gynecology training. Rubin explains that the visible head is just the tip of a large internal structure extending to the pelvic bones, with approximately 10,000 nerve endings. Most women do not orgasm from penetration alone; the clitoris is the main event for sexual pleasure. Despite this, medical education largely ignores the clitoris—no specialty actively teaches how to examine it, and future ob-gyn training requirements continue to omit meaningful coverage of clitoral anatomy and function. The practice of using sheets during exams further keeps women unfamiliar with their own anatomy, reducing opportunities for education and advocacy.
Approximately 23% of women experience clitoral adhesions, where the clitoral hood sticks to the head, limiting pleasure and function. Because clitoral exams are not standard practice, most women remain undiagnosed. Simple in-office procedures to release these adhesions can dramatically improve orgasm, arousal, and sexual satisfaction by 60-70%.
About 20% of women experience difficulty achieving orgasm, but Rubin emphasizes that the primary reason is lack of education rather than biology. Most women incorrectly believe penetrative sex alone should result in orgasm, yet the clitoris—not penetration—is how most women reach orgasm. Men reach orgasm after five and a half minutes of penetration, while women require significantly more time and, crucially, clitoral stimulation. Rubin notes that penetration without clitoral stimulation is like rubbing a thigh and expecting orgasm. Unlike men, women can potentially achieve multiple orgasms, as their period of sensitivity after climax is shorter. More awareness of clitoral physiology could help change dynamics, offering greater pleasure and satisfaction.
Up to 75% of women report having experienced painful sex, with causes including hormonally-sensitive skin diseases, scar tissue from endometriosis, nerve entrapments, and pelvic floor muscle dysfunction. Despite high prevalence, pain is frequently dismissed, and women rarely receive proper examination or diagnosis. Declining hormone levels, particularly estrogen and [restricted term], can cause dryness and loss of elasticity, increasing pain. Proper management—including vaginal hormone therapy—can restore healthy tissue, lubrication, and sexual function.
The pelvic floor consists of muscles that must contract and relax for healthy sexual response. Tight muscles can create burning, soreness, difficulty with penetration, impaired orgasms, and diminished arousal by restricting blood flow. Surgery, childbirth, and general muscle changes can lead to dysfunction. Specialist physical therapy can restore proper brain-genital connection and sexual function.
Genitourinary syndrome of menopause describes hormonal changes leading to vaginal and bladder symptoms, including dryness, decreased acidity, and imbalanced microbiome. Vaginal application of micro-doses of hormones effectively restores acidity, alleviates pain and dryness, and prevents UTIs. These therapies are safe for all ages—even for those with cancer, blood clot, or stroke histories. Despite these benefits, less than 25% of women are prescribed these vital treatments. Sexual activity introduces non-acidic semen and foreign bacteria, raising infection risk, making hormone therapy's maintenance of vaginal acidity especially protective.
Medical education's neglect of women's sexual health and hormonal care leaves doctors unprepared to meet women's needs. Rubin emphasizes that obstetrician-gynecologists still receive no formal training on the clitoris, vulva, sexual pain, libido, arousal, or orgasm. She notes that "the word clitoris today in 2026 does not exist in the checklist for what an OBGYN has to learn in their training." Despite this lack of education, physicians frequently express authoritative opinions on women's sexual health or hormone therapy, often denying treatments because it is easier than acknowledging knowledge gaps. Rubin, who comes from a men's health background, describes how "in men's health, we talk about risks, we talk about benefits, we talk about shared decision-making," while women are far more likely to hear "no, you can't have this" from gynecologists.
Rubin highlights that failures in women's healthcare cross socio-economic boundaries. Melinda Gates needed three doctors before anyone could properly prescribe hormone therapy, Oprah Winfrey saw five doctors before anyone recognized her menopause-related heart palpitations, and Halle Berry was misdiagnosed with genital herpes when she was actually experiencing genitourinary syndrome of menopause. Rubin underscores that "if the rich people are not getting good information about their bodies, about their hormonal health, about their sexual health, what are the rest of us doing?"
The long-lasting effects of fear and misinformation about hormone therapy have turned hormone prescribing into a "lost art" among physicians. Doctors are rarely taught how to write hormone prescriptions or discuss their risks and benefits. The lag between emerging research and its re-interpretation leads many physicians to default to unnecessary denial of care. Rubin argues it is far better for clinicians to admit their limitations and refer patients to specialists than to dismiss requests out of ignorance or fear.
Faced with systemic gaps, Rubin encourages women to actively advocate for themselves by seeking providers who are curious, up-to-date, and respectful, and leaving doctors who do not engage meaningfully or who restrict care without evidence. Crucially, Rubin emphasizes the power of education: "You can learn about your body parts, you can learn how hormones work in your body, and you can learn basic medicine for you that becomes important for how you advocate for what you want, what you care about, and who you bring into your medical life." Through self-advocacy and education, women can press for quality care, even in the face of persistent system-wide training gaps.
Steven Bartlett and Dr. Rachel Rubin explore how communication, lifestyle, media, and psychology all intersect to shape intimacy and satisfaction. Most couples rarely ask fundamental questions about what sexual satisfaction means for their partners, how they experience arousal, or what interests them. Bartlett admits that even in close relationships, he and others have bypassed these conversations, letting awkwardness prevent deeper dialogue. Rubin encourages explicit check-ins about physiology and pleasure, suggesting questions like "What does great sex mean for you?" She frequently brings both partners into clinical conversations and physical exams, allowing them to jointly discover physical sources of issues, replacing blame with understanding. These conversations work best outside moments of intimacy, when stakes are lower and thoughtful discussion is possible. A particularly charged area is the faked orgasm—Rubin asserts that many women fake orgasms to protect their partner's feelings, which ultimately prevents genuine intimacy and deprives both partners of true pleasure.
Rubin dismantles common male anxieties about penis size, rigidity, or duration, stating that women's satisfaction overwhelmingly depends on clitoral stimulation, emotional connection, and individualized understanding—not male anatomy. To truly enhance satisfaction, men should invest in learning their partner's unique anatomy and preferences. Many women require precise or indirect clitoral stimulation to orgasm, and disproportionate focus on penetration leaves many feeling broken when the real issue is lack of education and misplaced priorities.
Bartlett and Rubin recognize pornography's nuanced effects on sexual expectations. Mainstream content caters largely to male desires, instilling unrealistic ideas about women's pleasure. Heavy solo pornography use can desensitize the reward system, leading to performance anxiety and unrealistic standards. However, occasional partnered viewing, especially of female-oriented content, can enhance arousal and broaden understanding of desires. The emphasis is on honesty and intentionality—open discussion about porn is far more important than blanket moral judgments.
Modern life's stressors—overwork, sleep deprivation, continuous digital engagement, and mental burnout—drain [restricted term] and sap sexual desire. Rubin confirms these lifestyle challenges are common factors in patients presenting with low libido. Optimizing sleep, reducing screen time, and scheduling time for intimacy are practical interventions. Scheduling intimacy, often disparaged as unspontaneous, is reframed as anticipation and preparation that can reignite eroticism, just as date nights built anticipation during early courtship.
Body image insecurity is a profound barrier to sexual fulfillment. Rubin notes that women often fixate on thinness rather than building strength and self-acceptance, which are far more correlated with sexual pleasure. There is a marked cognitive distortion: while women believe their friends of any body type deserve pleasure, they do not extend the same compassion to themselves. Education on pleasure, biology, self-worth, and the diversity of desirability is vital for shifting these deeply embedded beliefs.
A crucial insight is the distinction between spontaneous and responsive arousal. Around 70% of men experience spontaneous arousal, while only 10–15% of women do. In contrast, 40–50% of women feel aroused responsively—meaning their desire emerges during engagement or foreplay, not in anticipation. Understanding responsive arousal helps debunk the myth that all sex should begin with overwhelming, instantaneous passion. What appears to be "low libido" or "lack of attraction" is often simply a normal arousal style responding to the right conditions and connection.
1-Page Summary
Hormones influence nearly every stage of a woman’s life, affecting sexual health, mood, sleep, and wider aspects of well-being. Yet, essential hormonal changes and available therapies often receive little clinical focus and are hindered by historical stigma and lack of public awareness.
Contrary to common belief, [restricted term] is not exclusive to men; women also produce this hormone. Rachel Rubin explains that women’s [restricted term] levels start to decline precipitously in the mid-to-late thirties, well before menopause. This drop can result in decreased libido, diminished clitoral engorgement and lubrication, slower or less intense orgasms, and reduced arousal. Clitoral erection, like penile erection, depends on blood flow driven by [restricted term].
Despite these significant effects, this decline garners little attention from clinicians, as medical education remains largely focused on estrogen and progesterone. Birth control pills can further lower [restricted term], leading to lower libido and sometimes painful sex in a subset of users. Rubin urges women who experience these side effects to discuss alternatives with their healthcare providers to find options that don’t impact [restricted term] as strongly. Personal anecdotes affirm that libido changes linked to birth control can resolve after discontinuation, though individual causes may vary.
Understanding the menstrual cycle’s hormonal changes is key to women’s health. The cycle starts with low estrogen and progesterone as menstruation begins. Estrogen rises in the early follicular phase to prepare an egg for release, while progesterone remains absent. During ovulation, estrogen peaks as an egg is released. The leftover egg shell then produces progesterone in the luteal phase, dominating the second half of the cycle and impacting mood, sleep, and sexual interest. If fertilization doesn’t occur, both hormones decrease, triggering menstruation.
[restricted term] typically remains stable throughout the menstrual cycle but peaks during ovulation. This coincides with heightened fertility and functions to increase sexual desire, which aids reproductive success. Estrogen measurements rise from roughly 50 at their lowest to 150–300 around ovulation, reaching 3000+ in pregnancy.
Perimenopause may begin as early as age 35 and is characterized by significant hormonal fluctuation. Rubin identifies a vast array of symptoms—temperature changes, fatigue, cognitive difficulties, joint pain, low libido, painful sex, frequent or recurrent UTIs, dry eyes, and irregular periods—that can all arise in this transitional period. Hormonal factors for bladder health and UTI prevention are especially overlooked.
Progesterone decline during perimenopause commonly disrupts sleep and increases anxiety. If a woman in her early forties reports poor sleep, low progesterone is often implicated. Since awareness of perimenopause’s early onset is low, symptoms are frequently misattributed or dismissed, leading to delayed diagnoses and interventions. Rubin emphasizes evolving awareness around offering hormone support as soon as perimenopausal symptoms appear.
Many women avoid hormone therapy due to outdated fears or misinformation, often passed down from relatives. This reluctance stems from a misinterpreted early-2000s study, the Women's Health Initiative. The researchers prematurely halted the study and warned—incorrectly—that hormone therapy caused cardiovascular disease and breast cancer. This led to an abrupt, industry-wide withdrawal from hormone prescriptions.
However, deeper examination revealed the study's actual data didn’t support these conclusions. In 2025, the same researchers published a reanalysis confirming that hormone therapy under age 70 does not increase cardiovascular or stroke risk. Despite this, a generation of physicians remain undertrained in hormone therapy, and only about 1.7% of eligible women are prescribed hormones—a public health failure as organ failure in any other system would never be so widely tolerated.
Rubin defines four categories of hormone therapy that can be combined or selected individually, tailored to symptoms and medical history:
Women's Hormones Across Life Stages and Hormone Therapy
The clitoris is central to women's sexual pleasure and orgasm, yet remains poorly understood and barely featured in gynecology training. Its visible part—the head—is just the tip; the clitoris is a large internal structure extending to the pelvic bones and is made of the same tissue as the penis, functioning similarly. With approximately 10,000 nerve endings, its sensitivity varies from person to person. While some find direct stimulation pleasurable, others may find it overwhelming and prefer indirect or external stimulation. Most women do not orgasm from penetration alone; rather, the clitoris is the main event for sexual pleasure and climax.
Despite this, medical education and gynecology largely ignore the clitoris. No specialty actively teaches how to examine or locate it, and during standard pelvic exams—when women are draped and unable to see their own anatomy—doctors rarely discuss the clitoris or invite patients to learn about their bodies. This lack of knowledge undermines women’s sexual health, pleasure, and ability to advocate for themselves.
Future ob-gyn training requirements continue to omit meaningful coverage of clitoral anatomy and function, resulting in clinicians who are unprepared to address clitoral sexual dysfunction or ask about a woman’s sexual satisfaction, even during pain or libido consultations.
The practice of using sheets to cover women during exams, though intended for modesty, also tends to keep women unfamiliar with their own genitalia, reducing opportunities for education and advocacy.
Approximately 23% of women experience clitoral adhesions, where the clitoral hood sticks to the head, often obscuring the full extent of the clitoris and limiting pleasure. Ideally, the clitoris has a mushroom shape similar to a penis, but adhesions hinder stimulation and function.
Because clitoral exams are not standard practice, most women remain undiagnosed for this manageable condition. However, simple in-office procedures to release these adhesions can yield dramatic improvements—boosting orgasm, arousal, and overall sexual satisfaction by 60-70%.
About 20% of women and men experience difficulty achieving orgasm, but for women, the primary reason is a lack of education rather than biology.
Despite clear evidence, most women believe penetrative sex alone should result in orgasm, largely because anatomical education is poor. The clitoris, not penetration, is how most women reach orgasm—yet many women don’t even know where their clitoris is or how to stimulate it. If sexual encounters focus solely on penetration, similar to continuously rubbing the thigh near a penis, orgasm is unlikely.
Normally, men reach orgasm after five and a half minutes of penetration, while women require significantly more time and, crucially, clitoral stimulation. Penetration without such stimulation yields little pleasure for most women, although some enjoy penetration due to additional nerve endings or individual preferences. The prevailing myth that penetration equals orgasm perpetuates the orgasm gap.
Unlike men, women can potentially achieve multiple orgasms, as their period of sensitivity and arousal after climax is shorter. Despite this, women often have no orgasms while men have one, due to focus on penile pleasure and the misconception that the male experience is standard. More awareness of clitoral physiology could help change this dynamic, offering greater pleasure and satisfaction.
Up to 75% of women report having experienced painful sex. Causes include hormonally-sensitive skin diseases (like eczema or autoimmune conditions), scar tissue from endometriosis, nerve entrapments, and, commonly, pelvic floor muscle dysfunction.
Despite high prevalence, pain is frequently dismissed, and women rarely receive the examination or diagnosis they deserve. Specialized pelvic pain management, including attention to anatomical, muscular, and hormonal factors, is rarely offered.
Declining hormone levels, particularly estrogen and [restricted term], can cause dryness and loss of elasticity, increasing pain. Proper management—including vaginal hormone therapy—can restore healthy tissue, lubrication, comfort, and sexual function.
The pelvic floor is a set of thick muscles supporting the pelvic organs and genitals. For healthy sexual response—including arousal, engorgement, penetration, and orgasm—these muscles must contract and relax in coordination. Tight muscles can create burn ...
Sexual Health, Dysfunction, and Anatomy
Medical education’s longstanding neglect of women’s sexual health and hormonal care leaves even the most experienced doctors unprepared to meet women’s needs. Dr. Rachel Rubin describes in detail how systemic failures impact care and patients’ ability to advocate for themselves.
Rachel Rubin emphasizes that the current medical education for obstetrician-gynecologists still fails to formally include essential aspects of female sexual anatomy and function. She notes that “the word clitoris today in 2026 does not exist in the checklist for what an OBGYN has to learn in their training.” In practice, most doctors specializing in obstetrics and gynecology never receive training on the clitoris, vulva, sexual pain, libido, arousal, or orgasm, despite their centrality to female sexual health. Only a small minority of gynecologists seek additional instruction on these topics. As a result, patients routinely enter appointments expecting expertise their doctors do not possess about hormones, sexual function, and pleasure.
Rubin points out that despite this lack of education, physicians frequently express authoritative opinions on women's sexual health or hormone therapy, often denying treatments because it is easier than acknowledging their knowledge gaps or discussing nuanced risks and benefits in short visits. She contrasts this with men’s health care, where shared decision-making about risks and benefits is standard. Rubin suggests this difference is not because doctors are malicious, but because they lack training and try to save face in brief consultations. She explains that many are taught to view hormones as inherently dangerous in older women—a misconception born from decades-old misinterpretation of science and lack of continuing education.
Rubin, who comes from a men’s health background, describes how “in men's health, we talk about risks, we talk about benefits, we talk about shared decision-making.” In contrast, women are far more likely to hear “no, you can’t have this” from gynecologists planning hormone therapies, a reflection of ingrained double standards and inadequate clinical education.
Rubin highlights that failures in women’s healthcare cross socio-economic boundaries. Melinda Gates publicly shared that she needed to see three doctors before anyone could properly prescribe hormone therapy. Oprah Winfrey saw five doctors before anyone recognized her menopause-related heart palpitations. Halle Berry, despite her resources, was misdiagnosed with genital herpes when she was actually experiencing genitourinary syndrome of menopause. These cases expose a system where even wealthy and well-connected women are not getting proper information, much less effective treatment. Rubin underscores that “if the rich people are not getting good information about their bodies, about their hormonal health, about their sexual health, what are the rest of us doing?” The core of the problem is inadequate education: doctors aren’t taught about these issues in medical school or residency, so many cannot effectively care for women experiencing menopause or sexual health concerns.
Rubin points to the long-lasting effects of fear and misinformation about hormone therapy that originated decades ago, turning hormone prescribing into a “lost art” among physicians. Doctors are rarely taught how to write hormone prescriptions, understand their differences, or discuss their risks and benefits with patients. Even large philanthropic contributions, like Melinda ...
Medical Education Gaps and Doctor-Patient Advocacy
Steven Bartlett and Dr. Rachel Rubin explore the multiple dimensions of sexual health, examining how communication, anatomy, lifestyle, media, and psychology all intersect to shape intimacy and satisfaction.
Most couples rarely ask their partners fundamental questions about what true sexual satisfaction means for them, how they experience arousal, or what types of sexual exploration interest them. Rubin observes that the default is to assume compatibility or avoid these vulnerable—yet potentially transformative—conversations. Bartlett candidly admits that even in close relationships, he and others have bypassed conversations about sexual satisfaction, letting awkwardness or discomfort prevent deeper dialogue. It is often assumed that if nothing is said, everything is fine, but as Bartlett points out, silence can mask unmet needs and dissatisfaction.
Rubin encourages explicit check-ins about physiology and pleasure, suggesting questions such as “What does great sex mean for you?” or “Where and how do you experience pleasure?” Partners should be curious about each other’s individual bodies and preferences, not just rely on generalizations. She also frequently brings both partners into her clinical conversations and physical exams, allowing them to jointly discover physical sources of issues—such as the pain at the vulva’s entrance—dismantling the notion that lack of desire is always about attraction or performance. Seeing the biology together replaces blame with understanding.
Importantly, Rubin and Bartlett agree these conversations work best outside moments of intimacy—when people are not naked or in the midst of foreplay—so that the stakes are lower, thoughtful discussion is possible, and neither partner feels pressured to perform or defend themselves.
Communication’s impact reverberates through all relationship health. Bartlett relates how conflict resolution—built on safe, honest, and caring communication—determines whether relationships become stronger or weaker after challenges. Open, vulnerable dialogue aids conflict healing, prevents misunderstandings from festering, and fosters enduring connection.
A particularly charged area is the faked orgasm. Rubin asserts that many women fake orgasms to protect their partner’s feelings, avoid uncomfortable discussions, or uphold an illusion of satisfaction, which ultimately prevents them from experiencing and communicating true pleasure. This pattern deprives both partners of genuine intimacy. Education, curiosity, and the courage to be honest are the foundations Rubin seeks to instill in her patients.
Rubin dismantles common male anxieties about penis size, rigidity, or duration. She states unequivocally that women’s satisfaction overwhelmingly depends on clitoral stimulation, emotional connection, mental engagement, and individualized understanding—not male anatomy. Obsessing over penile attributes diverts attention from what women actually need to feel pleasure.
To truly enhance sexual satisfaction, men should invest in learning their partner’s unique anatomy and preferences, asking about levels of arousal, sensitivity, and desired types of touch. A universal solution or formula does not exist. Recognizing and exploring the vast variability among women’s sexual responses—especially the prominence of clitoral stimulation—redirects the focus from penetration to the tangible sources of pleasure.
Rubin further stresses that many women require precise or indirect clitoral stimulation to orgasm, and this is both normal and healthy. Disproportionate focus on penetration leaves many women feeling broken or abnormal, when in fact the real issue is lack of education and misplaced priorities in sexual scripts.
Bartlett and Rubin recognize the nuanced effects of pornography on sexual expectations and satisfaction. Pornography—especially mainstream content—caters largely to male desires, instilling unrealistic ideas about women’s pleasure, body types, and sexual scripts. Many men learn about sex from porn and assume women enjoy the same acts, leading to misunderstandings and mutual dissatisfaction.
Heavy solo pornography use can desensitize the reward system, leading to performance anxiety, erectile issues in partnered sex, and unrealistic standards that diminish fulfillment in real-life intimacy. Deception about porn use, rather than the use itself, is particularly corrosive, breeding betrayal and insecurity between partners.
However, Rubin points out that not all porn consumption is negative. Occasional partnered viewing, especially of female-oriented or romantic erotic content, can enhance arousal, foster connection, and broaden understanding of desires. Some couples intentionally use pornography to manage mismatched libidos or bring novelty into their relationship with clear boundaries. The emphasis, once again, is on honesty and intentionality: open discussion about porn is far more important than blanket moral judgments.
Modern life’s stressors—overwork, sleep deprivation, continuous digital engagement, and mental burnout—drain [restricted term] and sap sexual desire for both men and women. Rubin confirms that these lifestyle challenges are common factors in patients presenting with low libido, often overshadowing biological causes.
Optimizing sleep, reducing screen time, engaging in regular exercise, and scheduling time for intimacy are practical interventions. Rubin admits even she finds it difficult to consistently prioritize well-being amid life’s demands, highlighting how pervasively lifestyle factors undermine sexual health. Creating intentional “white space” in a packed schedule ...
Communication, Relationships, and Lifestyle Factors in Sexual Health
Download the Shortform Chrome extension for your browser
